The DOI matches its Crossref record; 223 of the 223 references it cites were found in a registry or an index.
Glutamatergic targets for new alcohol medications
Open accessAbstract
Rationale An increasingly compelling literature points to a major role for the glutamate system in mediating the effects of alcohol on behavior and the pathophysiology of alcoholism. Preclinical studies indicate that glutamate signaling mediates certain aspects of ethanol's intoxicating and rewarding effects, and undergoes adaptations following chronic alcohol exposure that may contribute to the withdrawal, craving and compulsive drug-seeking that drive alcohol abuse and alcoholism.Objectives We discuss the potential for targeting the glutamate system as a novel pharmacotherapeutic approach to treating alcohol use disorders, focusing on five major components of the glutamate system: the N-methyl-D-aspartate (NMDA) receptor and specific NMDA subunits, the glycineB site on the NMDA receptors (NMDAR), L-alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid ionotropic (AMPA) and kainate (KAR) receptors, metabotropic receptors (mGluR), and glutamate transporters.Results Chronic alcohol abuse produces a hyperglutamatergic state, characterized by elevated extracellular glutamate and altered glutamate receptors and transporters. Pharmacologically manipulating glutamatergic neurotransmission alters alcohol-related behaviors including intoxication, withdrawal, and alcohol-seeking, in rodents and human subjects. Blocking NMDA and AMPA receptors reduces alcohol consumption in rodents, but side-effects may limit this as a therapeutic approach. Selectively targeting NMDA and AMPA receptor subunits (e.g., GluN2B, GluA3), or the NMDAR glycineB site offers an alternative approach. Blocking mGluR5 potently affects various alcohol-related behaviors in rodents, and mGluR2/3 agonism also suppresses alcohol consumption. Finally, glutamate transporter upregulation may mitigate behavioral and neurotoxic sequelae of excess glutamate caused by alcohol.Conclusions Despite the many challenges that remain, targeting the glutamate system offers genuine promise for developing new treatments for alcoholism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several studies established a causal role for reduced prefrontal metabotropic glutamate receptor 2 (mGluR2) function in craving and relapse responses in preclinical models of alcohol dependence [48–52].”
From Psilocybin-assisted therapy for severe alcohol use disorder: protocol for a double-blind, randomized, placebo-controlled, 7-month parallel-group phase II superiority trial (2024) · cites this paper as [51]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Rehm, J., Mathers, C., Popova, S., Thavorncharoensap, M., Teerawattananon, Y., & Patra, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60746-7 · Cited by 3,870
Anton, R. F., O’Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., Gastfriend, D. R., Hosking, J. D., Johnson, B. A., LoCastro, J. S., et al. (2006) · JAMA · doi:10.1001/jama.295.17.2003 · Cited by 1,930
Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793
Ethanol Inhibits NMDA-Activated Ion Current in Hippocampal Neurons
Lovinger, D. M., White, G., & Weight, F. F. (1989) · Science · doi:10.1126/science.2467382 · Cited by 1,448
Patil, S. T., Zhang, L., Martenyi, F., Lowe, S. L., Jackson, K. A., Andreev, B. V., Avedisova, A. S., Bardenstein, L. M., Gurovich, I. Y., Morozova, M. A., et al. (2007) · Nature Medicine · doi:10.1038/nm1632 · Cited by 1,040
Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis
Coyle, J. T. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9062-8 · Cited by 917
Drug Addiction as a Pathology of Staged Neuroplasticity
Kalivas, P. W., & O’Brien, C. P. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301564 · Cited by 761
Oral topiramate for treatment of alcohol dependence: A randomised controlled trial
Johnson, B. A., Ait-Daoud, N., Bowden, C. L., DiClemente, C. C., Roache, J. D., Lawson, K., Javors, M. A., & Ma, J. Z. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13370-3 · Cited by 743
Schoepp, D. D. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29296-x · Cited by 693
Cited by
Sorted by citations
Hazardous drinking and alcohol use disorders
MacKillop, J. M., Agabio, R., Ewing, S. W. F., Heilig, M. A., Kelly, J. F., Leggio, L., Lingford-Hughes, A. R., Palmer, A. A., Parry, C. D. H., Ray, L. A., et al. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00406-1 · Cited by 251
Potential Role of N-Acetylcysteine in the Management of Substance Use Disorders
McClure, E. A., Gipson, C. D., Malcolm, R. J., Kalivas, P. W., & Gray, K. M. (2014) · CNS Drugs · doi:10.1007/s40263-014-0142-x · Cited by 200
Structural and functional plasticity of dendritic spines – root or result of behavior?
Gipson, C. D., & Olive, M. F. (2016) · Genes Brain & Behavior · doi:10.1111/gbb.12324 · Cited by 214
Molecular mechanisms underlying alcohol-drinking behaviours
Ron, D., & Barak, S. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.85 · Cited by 165
Bukke, V. N., Archana, M., Villani, R., Romano, A. D., Wawrzyniak, A., Balawender, K., Orkisz, S., Beggiato, S., Serviddio, G., & Cassano, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207452 · Cited by 161
Targeting glutamate uptake to treat alcohol use disorders
Rao, P. S. S., Bell, R. L., Engleman, E. A., & Sari, Y. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00144 · Cited by 136
Cheng, Y., Huang, C. C., Ma, T., Wei, X., Wang, X., Lu, J., & Wang, J. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.05.016 · Cited by 135
Mann, K. F., Roos, C. R., Hoffmann, S., Nakovics, H., Leménager, T., Heinz, A., & Witkiewitz, K. A. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.282 · Cited by 131
Glutamate Signaling in Hepatic Stellate Cells Drives Alcoholic Steatosis
Choi, W., Kim, H., Kim, M., Çınar, R., Yi, H., Eun, H. S., Kim, S., Choi, Y. J., Lee, Y., Kim, S. Y., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.001 · Cited by 98
Meinhardt, M. W., Pfarr, S., Fouquet, G., Rohleder, C., Meinhardt, M. L., Barroso-Flores, J., Hoffmann, R., Jeanblanc, J., Paul, E., Wagner, K., et al. (2021) · Science Advances · doi:10.1126/sciadv.abh2399 · Cited by 89
Self-citationPostdependent state in rats as a model for medication development in alcoholism
Meinhardt, M. W., & Sommer, W. H. (2014) · Addiction Biology · doi:10.1111/adb.12187 · Cited by 87
Noori, H. R., Helinski, S., & Spanagel, R. (2014) · Addiction Biology · doi:10.1111/adb.12125 · Cited by 79
Self-citationAnticonvulsants for the Treatment of Alcohol Withdrawal Syndrome and Alcohol Use Disorders
Hammond, C. J., Niciu, M. J., Drew, S., & Arias, A. J. (2015) · CNS Drugs · doi:10.1007/s40263-015-0240-4 · Cited by 77
Repeated Binge Drinking Increases Perineuronal Nets in the Insular Cortex
Chen, H., He, D., & Lasek, A. W. (2015) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12847 · Cited by 77
Stefaniuk, M., Beroun, A., Lebitko, T., Markina, O. A., Łęski, S., Meyza, K. Z., Grzywacz, A., Samochowiec, J., Samochowiec, A., Radwańska, K., et al. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.12.026 · Cited by 70
Enoch, M., Rosser, A. A., Zhou, Z., Mash, D. C., Yuan, Q., & Goldman, D. A. (2014) · Genes Brain & Behavior · doi:10.1111/gbb.12179 · Cited by 70
Do specific NMDA receptor subunits act as gateways for addictive behaviors?
Hopf, F. W. (2016) · Genes Brain & Behavior · doi:10.1111/gbb.12348 · Cited by 66
Glutamatergic plasticity and alcohol dependence-induced alterations in reward, affect and cognition
Burnett, E. J., Chandler, L. J., & Trantham‐Davidson, H. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.08.012 · Cited by 66
Gimeno, C. P., Dorado, M. L., Roncero, C., Szerman, N., Vega, P., Balanzá‐Martínez, V., & Alvarez, E. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00173 · Cited by 63
From Pleasure to Pain, and Back Again: The Intricate Relationship Between Alcohol and Nociception
Robins, M. T., Heinricher, M. M., & Ryabinin, A. E. (2019) · Alcohol and Alcoholism · doi:10.1093/alcalc/agz067 · Cited by 63
Mihov, Y., & Hasler, G. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw002 · Cited by 56
Metabotropic glutamate receptor 5 binding in male patients with alcohol use disorder
Akkus, F., Mihov, Y., Treyer, V., Ametamey, S. M., Johayem, A., Senn, S., Rösner, S., Buck, A., & Hasler, G. (2018) · Translational Psychiatry · doi:10.1038/s41398-017-0066-6 · Cited by 56
Šerý, O., Sultana, N., Kashem, M. A., Pow, D. V., & Balcar, V. J. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1605-2 · Cited by 52
Reprogramming of mPFC transcriptome and function in alcohol dependence
Heilig, M. A., Barbier, E., Johnstone, A. L., Tapocik, J. D., Meinhardt, M. W., Pfarr, S., Wahlestedt, C., & Sommer, W. H. (2016) · Genes Brain & Behavior · doi:10.1111/gbb.12344 · Cited by 54
Tobore, T. O. (2019) · Substance Use & Misuse · doi:10.1080/10826084.2019.1645179 · Cited by 50
Glutamate Receptors within the Mesolimbic Dopamine System Mediate Alcohol Relapse Behavior
Eisenhardt, M., Leixner, S., Luján, R., Spanagel, R., & Bilbao, A. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2970-15.2015 · Cited by 49
Self-citationInteractions Between Alcohol and the Endocannabinoid System
Kunos, G. (2020) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14306 · Cited by 50
Reward, Relief and Habit Drinking: Initial Validation of a Brief Assessment Tool
Grodin, E. N., Bujarski, S., Venegas, A., Baskerville, W., Nieto, S. J., Jentsch, D., & Ray, L. A. (2019) · Alcohol and Alcoholism · doi:10.1093/alcalc/agz075 · Cited by 48
Too Difficult to Stop: Mechanisms Facilitating Relapse in Alcohol Dependence
Garbusow, M., Sebold, M., Beck, A., & Heinz, A. (2014) · Neuropsychobiology · doi:10.1159/000362838 · Cited by 47
Meyers, J. L., Salling, M. C., Almli, L. M., Ratanatharathorn, A. D., Uddin, M., Galea, S., Wildman, D. E., Aiello, A. E., Bradley, B., Ressler, K. J., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.70 · Cited by 42
The Need for Treatment Responsive Translational Biomarkers in Alcoholism Research
Heilig, M. A., Sommer, W. H., & Spanagel, R. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_5006 · Cited by 45
Self-citationSynaptic plasticity mechanisms common to learning and alcohol use disorderPreprint
Lovinger, D. M., & Abrahao, K. P. (2018) · Learning & Memory · doi:10.1101/lm.046722.117 · Cited by 47
Hwa, L., Besheer, J., & Kash, T. (2017) · F1000Research · doi:10.12688/f1000research.9609.1 · Cited by 39
Kranzler, H. R., Armeli, S., Feinn, R., Tennen, H. A., Gelernter, J. E., & Covault, J. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000510 · Cited by 40
Chronic alcohol alters rewarded behaviors and striatal plasticity
DePoy, L. M., Daut, R. A., Wright, T., Camp, M., Crowley, N. A., Noronha, B., Lovinger, D. M., & Holmes, A. (2014) · Addiction Biology · doi:10.1111/adb.12131 · Cited by 39
Self-citationMocelin, R., Marcon, M., Araújo, A. S. D. R., Herrmann, A. P., & Piato, Â. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.03.014 · Cited by 39
Zamora-Martinez, E. R., & Edwards, S. (2014) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2014.00024 · Cited by 37
Krishnan‐Sarin, S., O’Malley, S. S., Franco, N., Cavallo, D. A., Morean, M. E., Shi, J. M., Pittman, B. P., & Krystal, J. H. (2015) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12619 · Cited by 37
Self-citationMetabolic shift of the kynurenine pathway impairs alcohol and cocaine seeking and relapse
Vengeliene, V., Cannella, N., Takahashi, T. T., & Spanagel, R. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4384-9 · Cited by 37
Self-citationFredriksson, I., Jayaram-Lindström, N., Wirf, M., Nylander, E., Nyström, E., Jardemark, K., & Steensland, P. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.294 · Cited by 35
Kaarre, O., Kallioniemi, E., Könönen, M., Tolmunen, T., Kekkonen, V., Kivimäki, P., Heikkinen, N., Ferreri, F., Laukkanen, E., & Määttä, S. (2016) · Addiction Biology · doi:10.1111/adb.12486 · Cited by 33
Homer2 regulates alcohol and stress cross-sensitization
Quadir, S. G., dos Santos, J. R. B., Campbell, R. R., Wroten, M. G., Singh, N., Holloway, J. J., Bal, S. K., Camarini, R., & Szumlinski, K. K. (2015) · Addiction Biology · doi:10.1111/adb.12252 · Cited by 37
Lee, K. M., Coelho, M. A., Class, M. A., & Szumlinski, K. K. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.10.031 · Cited by 32
Wolfe, S. A., Workman, E. R., Heaney, C. F., Niere, F., Namjoshi, S. V., Cacheaux, L. P., Farris, S. P., Drew, M. R., Zemelman, B. V., Harris, R. A., et al. (2016) · Nature Communications · doi:10.1038/ncomms12867 · Cited by 31
Long‐lasting effect of NMDA receptor antagonist memantine on ethanol‐cue association and relapse
Vengeliene, V., Olevska, A., & Spanagel, R. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13350 · Cited by 31
Self-citationBahí, A. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.03.004 · Cited by 31
Ceccarini, J., Leurquin‐Sterk, G., Crunelle, C. L., de Laat, B., Bormans, G. M., Peuskens, H., & Laere, K. V. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.228825 · Cited by 32
Both ketamine and NBQX attenuate alcohol drinking in male Wistar rats
Kučerová, J., Babinská, Z., Ľupták, M., Getachew, B., & Tizabi, Y. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.12.055 · Cited by 30
Hillmer, A. T., Mason, G. F., Fucito, L. M., O’Malley, S. S., & Cosgrove, K. (2015) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12893 · Cited by 32
Different sites of alcohol action in the NMDA receptor GluN2A and GluN2B subunits
Zhao, Y., Ren, H., Dwyer, D. S., & Peoples, R. W. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.05.018 · Cited by 29
Memantine reduces alcohol drinking but not relapse in alcohol‐dependent rats
Alaux‐Cantin, S., Buttolo, R., Houchi, H., Jeanblanc, J., & Naassïla, M. (2014) · Addiction Biology · doi:10.1111/adb.12177 · Cited by 32
Zhornitsky, S., Ide, J. S., Wang, W., Chao, H. H., Zhang, S., Hu, S., Krystal, J. H., & Li, C. R. (2018) · Brain Connectivity · doi:10.1089/brain.2018.0633 · Cited by 30
Self-citationCortical GluN2B deletion attenuates punished suppression of food reward-seeking
Radke, A. K., Nakazawa, K., & Holmes, A. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4033-8 · Cited by 29
Self-citationKetamine Differentially Attenuates Alcohol Intake in Male Versus Female Alcohol Preferring (P) Rats
Rezvani, A. H., Levin, E. D., Cauley, M. C., Getachew, B., & Tizabi, Y. (2017) · Journal of Drug and Alcohol Research · doi:10.4303/jdar/236030 · Cited by 28
Novel medications for problematic alcohol use
Heilig, M. A., Witkiewitz, K. A., Ray, L. A., & Leggio, L. (2024) · Journal of Clinical Investigation · doi:10.1172/jci172889 · Cited by 28
Lee, J., Jee, Y.-M., Yang, K., & Ryu, T. (2025) · Antioxidants · doi:10.3390/antiox14101196 · Cited by 31
What the alcohol doctor ordered from the neuroscientist
Heilig, M., & Leggio, L. (2016) · Progress in Brain Research · doi:10.1016/bs.pbr.2015.07.023 · Cited by 25
Nona, C. N., Li, R., & Nóbrega, J. N. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.11.037 · Cited by 25
NEUROBIOLOGICAL BASES OF ALCOHOL ADDICTION
Matošić, A. (2016) · Acta Clinica Croatica · doi:10.20471/acc.2016.55.01.19 · Cited by 25
Harda, Z., Łukasiewicz, K., Ziółkowska, M., Lipiński, M., Cały, A., Matuszek, Ż., Łęski, S., & Radwańska, K. (2015) · Addiction Biology · doi:10.1111/adb.12327 · Cited by 25
Effect of Intravenous Ethanol on Capsaicin-Induced Hyperalgesia in Human Subjects
Arout, C. A., Perrino, A. C., Ralevski, E., Acampora, G. A., Koretski, J. A., Limoncelli, D., Newcomb, J., & Petrakis, I. L. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13095 · Cited by 23
GluN2B Subunit of the NMDA Receptor: The Keystone of the Effects of Alcohol During Neurodevelopment
Naassïla, M., & Pierrefiche, O. (2018) · Neurochemical Research · doi:10.1007/s11064-017-2462-y · Cited by 23
Do Alcohol-Related AMPA-Type Glutamate Receptor Adaptations Promote Intake?
Hopf, F. W., & Mangieri, R. A. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_105 · Cited by 20
Ginsenoside Rg1 alleviates repeated alcohol exposure-induced psychomotor and cognitive deficits
Huang, L., Zhuang, P., Lü, C., Chen, Y., Lv, J., Qin, M., Liao, D., Liu, X., & Shi, Z. (2020) · Chinese Medicine · doi:10.1186/s13020-020-00325-x · Cited by 23
Pharmacotherapeutic options for co-morbid depression and alcohol dependence
Hillemacher, T., & Frieling, H. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1561870 · Cited by 24
Domanegg, K., Sommer, W. H., & Meinhardt, M. W. (2023) · Cells · doi:10.3390/cells12060963 · Cited by 24
Verplaetse, T. L. (2018) · Alcohol research · doi:10.35946/arcr.v39.2.09 · Cited by 22
Quantification of alcohol drinking patterns in mice
Eisenhardt, M., Leixner, S., Spanagel, R., & Bilbao, A. (2015) · Addiction Biology · doi:10.1111/adb.12325 · Cited by 21
Self-citationFaccidomo, S., Cogan, E. S., Hon, O. J., Hoffman, J. L., Saunders, B. L., Eastman, V. R., Kim, M. J., Taylor, S. M., McElligott, Z. A., & Hodge, C. W. (2021) · Addiction Biology · doi:10.1111/adb.13049 · Cited by 21
Clinical Neuroscience of Addiction: Similarities and Differences Between Alcohol and Other Drugs
Karoly, H. C., YorkWilliams, S. L., & Hutchison, K. E. (2015) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12884 · Cited by 19
Irimia, C., Buczynski, M. W., Natividad, L. A., Laredo, S. A., Avalos, L. N., & Parsons, L. H. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.2466-16.2017 · Cited by 19
Pradhan, G., Melugin, P. R., Wu, F., Fang, H. M., Weber, R. E., & Kroener, S. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4900-1 · Cited by 21
Hoffman, J. L., Faccidomo, S., Saunders, B. L., Taylor, S. M., Kim, M., & Hodge, C. W. (2021) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14639 · Cited by 16
Knapp, C. M., Ciraulo, D. A., & Datta, S. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.08.029 · Cited by 19
Implication of Genes for the N-Methyl-d-Aspartate (NMDA) Receptor in Substance Addictions
Chen, J., Ma, Y., Fan, R., Yang, Z., & Li, M. D. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0877-3 · Cited by 18
Agostini, J. F., Costa, N. L. F., Bernardo, H. T., Baldin, S. L., Mendes, N. V., Pickler, K. D. P., Manenti, M. C., & Rico, E. P. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03008-z · Cited by 18
Kalejaiye, O., Getachew, B., Ferguson, C. L., Taylor, R. E., & Tizabi, Y. (2017) · Journal of Drug and Alcohol Research · doi:10.4303/jdar/236036 · Cited by 17
Both Ketamine and NBQX Attenuate Alcohol-Withdrawal Induced Depression in Male Rats
Getachew, B., & Tizabi, Y. (2018) · Journal of Drug and Alcohol Research · doi:10.4303/jdar/236069 · Cited by 17
Sobriety and Satiety: Is NAD+ the Answer?
Braidy, N., Villalva, M. D., & van Eeden, S. (2020) · Antioxidants · doi:10.3390/antiox9050425 · Cited by 17
Contreras, A., Morales, L., & Olmo, N. D. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112033 · Cited by 17
Effect of ketamine on binge drinking patterns in crossed high alcohol-preferring (cHAP) mice
Ardinger, C. E., Winkler, G. A., Lapish, C. C., & Grahame, N. J. (2021) · Alcohol · doi:10.1016/j.alcohol.2021.09.004 · Cited by 16
Miller, E. M., Quintero, J. E., Pomerleau, F., Huettl, P. F., Gerhardt, G. A., & Glaser, P. E. A. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2483-1 · Cited by 16
Fish oil treatment reduces chronic alcohol exposure induced synaptic changes
Shi, Z., Xie, Y., Ren, H., He, B., Wang, M., Wan, J., Yuan, T., Yao, X., & Su, H. (2018) · Addiction Biology · doi:10.1111/adb.12623 · Cited by 18
Targeting Glycine Reuptake in Alcohol Seeking and Relapse
Vengeliene, V., Roßmanith, M., Takahashi, T. T., Alberati, D., Behl, B., Bespalov, A., & Spanagel, R. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.244822 · Cited by 16
Self-citationAlcohol use and the pain system
Vigorito, M., & Chang, S. L. (2024) · Advances in Drug and Alcohol Research · doi:10.3389/adar.2024.12005 · Cited by 15
Radke, A. K., Jury, N. J., Delpire, E. J., Nakazawa, K., & Holmes, A. (2016) · Alcohol · doi:10.1016/j.alcohol.2016.07.005 · Cited by 15
Self-citationHeikkinen, N., Kärkkäinen, O. K., Laukkanen, E., Kekkonen, V., Kaarre, O., Kivimäki, P., Könönen, M., Velagapudi, V., Nandania, J., Lehto, S. M., et al. (2018) · Alcohol · doi:10.1016/j.alcohol.2018.05.010 · Cited by 15
Impaired discrimination learning in interneuronal NMDAR-GluN2B mutant mice
Brigman, J. L., Daut, R. A., Saksida, L. M., Bussey, T. J., Nakazawa, K., & Holmes, A. (2015) · Neuroreport · doi:10.1097/wnr.0000000000000373 · Cited by 15
Self-citationMoaddab, M., Mangone, E., Ray, M. H., & McDannald, M. A. (2017) · Brain Sciences · doi:10.3390/brainsci7110151 · Cited by 14
Puhakka, E., Ahmed, H., Haikonen, R., Leclercq, S., Hanhineva, K., Maccioni, L., Amadieu, C., Lehtonen, M., Männistö, V., Rysä, J., et al. (2025) · Liver International · doi:10.1111/liv.70128 · Cited by 14
mGlu2 mechanism-based interventions to treat alcohol relapse
Vengeliene, V., & Spanagel, R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.985954 · Cited by 14
Self-citationZhao, Y., Ren, H., & Peoples, R. W. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13487 · Cited by 14
Alén, F., Decara, J. M., Brunori, G., You, Z., Bühler, K., López‐Moreno, J. A., Cippitelli, A., Pavón, F. J., Suárez, J., Gardner, E. L., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.09.008 · Cited by 14
Barros, J. B. D. S., Santos, K. D. F., Azevedo, R. M., de Oliveira, R. P. D., Leobas, A. C. D., Bento, D. D. C. P., Santos, R. D. S., & Reis, Â. A. D. S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247024 · Cited by 14
Vanderijst, L., Hever, F., Buot, A., Dauré, C., Benoit, J., Hanak, C., Veeser, J., Morgiève, M., Campanella, S., Kornreich, C., et al. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05502-y · Cited by 13
COR758, a negative allosteric modulator of GABAB receptors
Porcu, A., Mostallino, R., Serra, V., Melis, M., Sogos, V., Beggiato, S., Ferraro, L., Manetti, F., Gianibbi, B., Bettler, B., et al. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108537 · Cited by 13
Evaluation of alcohol use disorders pharmacotherapies in a new preclinical model of binge drinking
González‐Marín, M. C., Lebourgeois, S., Jeanblanc, J., Diouf, M., & Naassïla, M. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.07.015 · Cited by 16
Hillmer, A. T., Angarita, G. A., Esterlis, I., Anderson, J. M., Nabulsi, N., Lim, K., Ropchan, J. R., Carson, R. E., Krystal, J. H., Malley, S., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00856-9 · Cited by 13
Self-citationFilarowska, J., Komsta, Ł., Smaga, I., Surówka, P., Marszałek‐Grabska, M., Grochecki, P., Nizio, D., Filip, M., & Kotlinska, J. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105350 · Cited by 13
Lutz, J. A., Carter, M., Fields, L., Barron, S., & Littleton, J. M. (2015) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12705 · Cited by 12
Metadata
- Authors
- Holmes, A., Spanagel, R., & Krystal, J. H.
- Affiliations
- National Institutes of Health (US)
- Heidelberg University (DE)
- Yale University (US)
- Corresponding author
- Holmes, Andrew
- Venue
- Psychopharmacology
- Published
- 2013-09-01
- Volume
- 229
- Issue
- 3
- Pages
- 539-554
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- PMC
- PMC3811052
- OpenAlex
- W2104412023
- Cited by
- 197
- References
- 221
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 10 · 2023: 5 · 2022: 7 · 2021: 15 · 2020: 16 · 2019: 15 · 2018: 22 · 2017: 14 · 2016: 25 · 2015: 29 · 2014: 17 · 2013: 1
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Alcohol Abuse and Alcoholism (P50AA012870, ZIAAA000411)
- National Center for Research Resources (UL1RR024139)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- glutamatergic system, alcoholism, alcoholism pharmacotherapy, NMDA receptor, NMDA receptor glycine site, AMPA receptors, kainate receptors, metabotropic glutamate receptors, mGluR5, glutamate transporters, GluN2B, GluA3, alcohol withdrawal, alcohol craving, alcohol seeking, chronic ethanol exposure, glutamate excitotoxicity
- MeSH terms
- Alcoholism, Animals, Humans, Substance Withdrawal Syndrome, Receptors, N-Methyl-D-Aspartate, Receptors, AMPA, Kainic Acid Receptors, Glutamic Acid, Protein Subunits, Molecular Targeted Therapy, Drug-Seeking Behavior
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review